Cytokine Communication Between Neurons and Glia and the Pathogenesis of Alzheimer’s Disease

  • B. Cordell
  • L. Yang
  • A. Naidu
  • K. Bales
  • S. Paul
  • G. Murphy
Conference paper
Part of the Research and Perspectives in Neurosciences book series (NEUROSCIENCE)


Brain inflammation is a key feature in the development of Alzheimer’s disease. Numerous inflammatory markers can be observed in afflicted brain regions by immunohistochemical analysis. Epidemiological studies indicate that exposure to anti-inflammatory drugs can delay the onset of this disease. Microglia are likely to have a pivotal role in this inflammatory process since these cells are potent mediators of cerebral inflammation. Microglia have also been found specifically associated with β-amyloid deposits that progress into mature neuritic plaques, structures that are considered to be intimately connected with the pathology and progression of the disease. We have examined β-amyloid-induced inflammatory responses in a murine microglial cell line, BV-2. We have found that exposure of BV-2 cells to exogenous β-amyloid induces secretion of endogenous β-amyloid. Furthermore, β-amyloid exposure results in pro-inflammatory events, such as the translocation of the transcriptional activator, NF-kB, and a 2- to 5-fold induction of IL-1 and IL-6. Exposure of neurons to β-amyloid peptide has been reported to induce release of macrophage-colony stimulating factor (M-CSF). Because microglia are target cells for M-CSF and because M-CSF is found at increased levels in the central nervous system in Alzheimer’s disease, we examined the effects of this cytokine on the inflammatory activation of BV-2 cells. We found that while MCSF and β-amyloid each have modest effects on BV-2 cytokine production, together these two molecules act synergistically to dramatically generate IL-1, IL-6, and nitric oxide. Identical results have been obtained in rat organotypic hippocampal cultures. Each of these molecules has been shown to injure neurons and to activate astrocytes causing further neuronal injury. These results have been used to build a model for a self-amplifying pathological cascade in Alzheimer’s disease involving cytokine communication between neurons, microglia, and astrocytes


Nitric Oxide Neuritic Plaque Diffuse Deposit Cerebral Inflammation Murine Microglial Cell Line 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Akiyama H, Nishimura T, Kondo, H, Ikeda K, Hayashi Y, McGeer PL (1994) Expression of the receptor for macrophage colony stimulating factor by brain microglia and its upregulation in brains of patients with Alzheimer’s disease. Brain Res 639:171–174PubMedCrossRefGoogle Scholar
  2. Araujo DM, Cotman CW (1992) β-Amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer’s disease. Brain Res 569:141–145PubMedCrossRefGoogle Scholar
  3. Baldwin AS (1996) The NF-kB and IkB proteins: new discoveries and insights. Annu Rev Immunol 14:649–681PubMedCrossRefGoogle Scholar
  4. Bauer J, Strauss S, Schreiter-Gasser U, Ganer U, Schlegel P, Witt I, Yolk B, Berger M (1991) Interleukin-6 and alpha-2-macroglobulin indicate an acute-phase state in Alzheimer’s disease cortices. FEBS Lett 285:111–114PubMedCrossRefGoogle Scholar
  5. Bitting L, Naidu A, Cordell B, Murphy GM (1996) β-Amyloid peptide secretion by a microglial cell line is induced by β-amyloid (25-35) and lipopolysaccharide. J Biol Chem 271:16084–16089PubMedCrossRefGoogle Scholar
  6. Bocchini V, Mazzolla R, Barluzzi R, Blasi E, Sick P Kettenmann H (1992) An immortalized cell line expressed properties of activated microglial cells. J Neurosci Res 31:616–621PubMedCrossRefGoogle Scholar
  7. Cotman CW, Tenner AJ, Cummings BJ (1996) β-Amyloid converts an acute phase injury response to chronic injury response. Neurobiol Aging 17:723–731PubMedCrossRefGoogle Scholar
  8. Davies CA, Mann DMA, Sumpter PQ, Yates PO (1987) A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer’s disease. J Neurol Sci 78:151–164PubMedCrossRefGoogle Scholar
  9. Davis JB, McMurray HF, Schubert D (1992) The amyloid beta-protein of Alzheimer’s disease is chemotactic for mononuclear phagocytes. Biochem Biophys Res Commun 189:1096–1100PubMedCrossRefGoogle Scholar
  10. Ding M, St. Pierre BA, Parkinson JF, Medberry P, Wong JL, Rogers NE, Ignarro LJ, Merrill JE (1997) Inducible nitric oxide synthase and nitric oxide production in human fetal astrocytes and microglia: a kinetic study. J Biol Chem 272:11327–11335PubMedCrossRefGoogle Scholar
  11. Gitter BD, Cox LM, Rydell RE, May PC (1995) Amyloid ft peptide potentiates cytokine secretion by interleukin lβ-activated human astrocytoma cells. Proc Natl Acad Sci USA 92:10738–10741PubMedCrossRefGoogle Scholar
  12. Giulian D, Ingeman JE (1988) Colony stimulating factors as promoters of ameboid microglia. J Neurosci 8:4707–4717PubMedGoogle Scholar
  13. Griffin WST, Sheng JG, Roberts GW, Mrak RE (1995) Interleukin-1 expression in different plaque types in Alzheimer’s disease: significance in plaque evolution. J Neuropathol Exp Neurol 54:276–281PubMedCrossRefGoogle Scholar
  14. Hamilton J (1997) CSF-1 singal transduction: what is of functional significance? Immunol Today 18:313–317PubMedCrossRefGoogle Scholar
  15. Hao C, Guilbert LJ, Federfoo S (1990) Production of colony-stimulating factor-1 (CSF-1) by mouse astroglia in vitro. J Neurosci Res 27:314–323PubMedCrossRefGoogle Scholar
  16. Hardy J (1997) Amyloid, the presenilins and Alzheimer’s disease. Trends Neurosci 20:154–159PubMedCrossRefGoogle Scholar
  17. Hu J, Akama KT, Krafft GA, Chromy BA, VanEldik LJ (1998) Amyloid β peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release. Brain Res 785:195–206PubMedCrossRefGoogle Scholar
  18. Ii M, Sunamoto M, Ohnishi K, Ichimori Y (1996) β-Amyloid protein-dependent nitric oxide production from microglial cells and neurotoxicity. Brain Res 720:93–100PubMedCrossRefGoogle Scholar
  19. Ikeda SI, Allsop D, Glenner GG (1989) Morphology and distribution of plaque and related deposits in the brain of Alzheimer’s disease and control cases. Lab Invest 60:113–122PubMedGoogle Scholar
  20. Khoury JE, Hickman SE, Thomas CA, Cao L, Silverstein S, Loike JD (1996) Scavenger receptormediated adhesion of microglia to amyloid fibrils. Nature 382:716–719PubMedCrossRefGoogle Scholar
  21. Klegeris A, Walker DG, McGeer PL (1994) Activation of macrophages by Alzheimer β-amyloid peptide. Biochem Biophys Res Comm 199:984–991PubMedCrossRefGoogle Scholar
  22. Lee SC, Liu W, Roth P, Dickson D, Berman JW, Brosnan CF (1993) Induction of nitric oxide synthase in human astrocytes by interleukin-lβ and interferon-y. J. Immunol 150:594–604PubMedGoogle Scholar
  23. London JA, Biegel D, Patcher JS (1996) Neurocytopathic effects of β-amyloid-stimulated monocytes: a potential mechanism for central nervous system damage in Alzheimer’s disease. Proc Natl Acad Sci USA 93:4147–4152PubMedCrossRefGoogle Scholar
  24. McGeer PL, Schulzer M, McGeer EG (1996) Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer’s disease: a review of 17 epidemiologic studies. Neurol 47:425–432Google Scholar
  25. Meda L, Cassatella MA, Szendrel GI, Otvos L, Baron P, Villalba M, Ferrari D, Rossi F (1995) Activation of microglial cells by P~amyloid protein and interferon-y. Nature 374:647–650PubMedCrossRefGoogle Scholar
  26. Merrill JE, Benveniste EN (1996) Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci 12:331–338CrossRefGoogle Scholar
  27. Mrak RE, Sheng JG, Griffin WST (1995) Glial cytokines in Alzheimer’s disease: review and pathologic implications. Human Pathol 26:816–823CrossRefGoogle Scholar
  28. Murphy GM, Ynag L, Cordell B (1998) Macrophage colony-stimulating factor augments amyloid-induced interleukin-1, interleukin-6, and nitric oxide production by microglia cells. J Biol Chem 273:20967–20971PubMedCrossRefGoogle Scholar
  29. Paresce DM, Ghosh RN, Maxfield FR (1996) Microglial cells internalize aggregates of the Alzheimer’s disease amyloid β-protein via a scavenger receptor. Neuron 17:553–565PubMedCrossRefGoogle Scholar
  30. Perlmutter LS, Scott SA, Barron E, Chui HC (1992) MHC class II-positive microglia in human brain: association with Alzheimer’s lesions. J Neurosci Res 33:549–558PubMedCrossRefGoogle Scholar
  31. Rogers J, Kirby LC, Hempelman SR, Berry DL, McGeer PL, Kaszniak AW, Zalinski J, Cofield M, Mansukhani L, Willson P, Kogan F (1993) Clinical trials of indomethacin in Alzheimer’s disease. Neurology 43:1609–1611PubMedGoogle Scholar
  32. Samuel W, Terry RD, DeTeresa R (1994) Clinical correlates of cortical and nucleus basalis pathology in Alzheimer’s disease. Arch Neurol 51:772–778PubMedGoogle Scholar
  33. Selkoe D (1997) Alzheimer’s disease: genotypes, phenotypes, and treatments. Science 275:630–631PubMedCrossRefGoogle Scholar
  34. Sheng JG, Mrak RE, Griffin WST (1997) Neuritic plaque evolution in Alzheimer’s disease is accompanied by transition of activated microglia from primed to phagocytic forms. Acta Neuropathol 94:1–5PubMedCrossRefGoogle Scholar
  35. Singh VK, Guthikonda P (1997) Circulating cytokines in Alzheimer’s disease. J Psychiat Res 6:657–660CrossRefGoogle Scholar
  36. Smith MA, Richey-Harris PL, Sayre LM, Beckman JS, Perry G (1997) Widespread peroxynitrite mediated damage in Alzheimer’s disease. J Neurosci 17:2653–2657PubMedGoogle Scholar
  37. Stancovski I, Baltimore D (1997) NF-kB activation: the lkB kinase revealed? Cell 91:299–302PubMedCrossRefGoogle Scholar
  38. Stewart WF, Kawas C, Corrada M, Metter EJ (1997) Risk of Alzheimer’s disease and duration of NSAID use. Neurol 48:626–632Google Scholar
  39. Strittmatter WJ, Roses AD (1996) Apolipoprotein E and Alzheimer’s disease. Annu Rev Neurosci 19:53–77PubMedCrossRefGoogle Scholar
  40. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R (1991) Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30:572–580PubMedCrossRefGoogle Scholar
  41. Thery C, Stanley ER, Mallat MJ (1992) Interleukin-1 and tumor necrosis factor-alpha stimulate the production of colony stimulating factor 1 by murine astrocytes. J Neurochem 59:1183–1186PubMedCrossRefGoogle Scholar
  42. Yan SD, Zhu H, Fu J, Yan SF, Roher A, Tourtellotte WW, Rajavashisth T, Chen X, Godman GC, Stern D, Schmidt AM (1997) Amyloid-β peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer’s disease. Proc Natl Acad Sci USA 94:5296–5301PubMedCrossRefGoogle Scholar
  43. Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, Slattery T, Zhao L, Nagashima M, Morser J, Migheli A, Nawroth P, Stern D, Schmidt AM (1996) RAGE and β-amyloid peptide neurotoxicity in Alzheimer’s disease . Nature 382:685–691PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2000

Authors and Affiliations

  • B. Cordell
  • L. Yang
  • A. Naidu
  • K. Bales
  • S. Paul
  • G. Murphy

There are no affiliations available

Personalised recommendations